Exploring Marine Sponge Metabolites as Next-Generation Anticoagulant Agents

Thrombotic and cardiovascular diseases constitute major global health problems because they rank among the top reasons people get sick and die throughout the world. Anticoagulant therapy functions as an essential treatment method which helps patients avoid thromboembolic events while also treating these medical conditions. The current anticoagulants which include heparin and warfarin and direct oral anticoagulants (DOACs) present numerous challenges because they create bleeding dangers and drug interaction problems and they have narrow treatment ranges and their extended use creates safety issues. The existing problems with anticoagulant agents demonstrate an urgent requirement for new anticoagulant drugs which offer better safety features and more reliable performance. The vast biological diversity and distinct chemical properties of marine ecosystems create an exceptional opportunity to discover new therapeutic drugs which remain mostly unexplored. Sponges from the Porifera phylum function as the main sources which produce bioactive secondary metabolites in marine environments. The simple body structure of sponges together with their microbial symbiotic relationships enables them to create a wide range of chemical substances that contain valuable medicinal properties. Marine sponge metabolites exist in several different classes which include sulfated polysaccharides and alkaloids and terpenoids and steroids and peptides and glycosaminoglycan-like molecules because most of these substances demonstrate powerful anticoagulant properties. The compounds produce their effects through several pathways which include thrombin and factor Xa coagulation factor inhibition and antithrombin III activation and platelet aggregation suppression and fibrin formation disruption. The studies which used in vitro coagulation assays and in vivo thrombosis models produced results that showed anticoagulant effectiveness with potentially reduced side effects when compared to traditional medications. The advantages which exist with these benefits face multiple obstacles which need to be addressed before proceeding.